Wow, and that's off the back of the ONE FDA approved drug....MC of $USD 3.93B or $AUD 5.86B
From the GW Pharma web site:-
Sound familiar? Why can't we be the Oz version of GW Pharma, we're adopting the same strategy, have a very astute BOD and the best medicos in the business involved in these trials.
I would have thought that we'd be appealing to a much larger market as well (Sleep Apnea vs Rare form of Epilepsy) .....mind boggling what could be achieved here.....
IHL Price at posting:
6.1¢ Sentiment: Buy Disclosure: Held